Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Panel reviews H237 to allow prescribing by doctoral-level psychologists under collaborative agreements
Summary
A legislative committee reviewed H237, which would authorize a prescribing specialty for doctoral-level psychologists working under collaborative agreements with psychiatrists. Staff described training, scope limits, $100 initial specialty fee and reporting requirements; senators pressed for medical justification on age cutoffs and patient-continuity safeguards.
A legislative committee on Tuesday reviewed House bill H237, a draft that would authorize a prescribing specialty for doctoral-level psychologists working in a documented collaborative relationship with a psychiatrist.
Legislative staff said the bill adds definitions to the psychologists chapter (Title 26), establishes a ‘‘prescribing psychologist’’ specialty, and requires collaborative written agreements filed with the board of psychologists. ‘‘They would collaborate with a psychiatrist and they'd be able to prescribe the same types of medications that the psychiatrist regularly prescribes,’’ said Katie, a legislative staff member who walked the panel through the draft.
Staff described the credentialing and training pathway in the bill: eligibility requires a current doctoral-level psychology license, completion of a postdoctoral psychopharmacology program designated by the American Psychological Association (or successor), a national certifying exam, and a period of clinical rotations…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
